Skip to content

Rezum for men with a catheter or on blood thinners

What the studies show about Rezum in men who depend on a catheter and in men who take blood thinners.

Dr. Petronio Melo, urologistA reference in enlarged prostate (BPH) treatment
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 14, 2026
Book a consultation
Front-view drawing of an enlarged prostate, with the areas treated by Rezum vapor in both lobes and the catheter running through the urethra into the bladder, with the balloon above the bladder neck
On this page

Quick answer

Men who depend on a catheter because of an enlarged prostate can have Rezum. In a review of 24 studies, the catheter was removed in 68% to 100% of men treated with Rezum.2 In these cases, it usually comes out later than in men who did not have a catheter.4,6 Men on anticoagulants or antiplatelet drugs can also have it, with a higher chance of blood in the urine in the first days.9,10 The decision about the medication is made case by case, together with the doctor who prescribed it.

For men who depend on a catheter

When an enlarged prostate closes the passage and urine cannot come out, the bladder needs a catheter. If the catheter cannot be removed, surgery is usually needed. Men in this situation are often older and have other illnesses, and the studies that brought the less invasive techniques into practice generally left them out.2 Urinary retention has its own page.

Schematic animation of Rezum. The device and the needle are simplified.

A 2026 review gathered 24 studies, with 1,137 men who depended on a catheter and were treated with less invasive techniques. Rezum and prostatic artery embolization were the most studied. After Rezum, the catheter was removed in 68% to 100% of cases, and the need for retreatment was generally below 15%. Serious complications were rare.2 Most of these studies looked back at records and had no comparison group.

Some studies show what to expect:

  • In Italy, 70 frail men who had used a catheter for 6 months or more had Rezum. The catheter was removed in 94%, and none of them needed it again within 1 year.3
  • In Canada, 53 men who had used a catheter for 225 days on average were treated. 79% became catheter-free, but 49% could not void at the first attempt, at 14 days. Blood in the urine occurred in 11%.4
  • In Hong Kong, 23 men with acute retention and worsening kidney function had Rezum under local anesthesia, without a hospital stay. At 1 year, 96% were catheter-free with stable kidney function.8
  • In a study from Saudi Arabia of 81 men treated with Rezum and 81 with TURP, 90.2% and 92.7% voided without a catheter. The catheter stayed longer after Rezum, and the operation and hospital stay were shorter.7

How long the catheter stays afterward

In men who already depended on a catheter, it usually stays longer after Rezum than in other patients. In a two-center registry of 38 men, those who voided again were catheter-free after about 26 days, as a median.6 In acute retention with worsening kidney function, the catheter came out after about 36 days, also as a median.8 A consensus of urologists from Asia and the Pacific considers it reasonable to repeat attempts to remove the catheter for up to 3 months and to keep the prostate medications at least until the first successful removal.12

In a Canadian study, having drained 1 liter or more of urine at the time of retention was the only factor linked to failure.4 In a Swiss series, having a catheter beforehand and having a median lobe raised the risk that the catheter could not be removed.13 What the studies show about the median lobe is in Rezum for a large prostate and median lobe.

In Hong Kong, a group compared the usual technique with a way of planning more vapor injections, dividing the prostate into a front part and a back part. With more injections (10.4 vs 6.7), the prostate shrank more at 3 months and the symptom score was better at 1 year (3.7 vs 8.1).5

A catheter can also raise the PSA. For that reason, the Asian consensus recommends discussing when to measure PSA in men who depend on a catheter, and one option is to measure it after treatment, once the catheter is out.12

For men on anticoagulants or antiplatelet drugs

Anticoagulants and antiplatelet drugs are blood thinners, used for example for arrhythmia or after a stent. A review described little bleeding with Rezum, similar to a prostate biopsy, because the vapor is delivered at specific points and the procedure is short. The same review noted that there are few direct studies and that urological societies have no formal recommendation on the matter.11

Two studies from Japan followed men who stayed on these drugs during Rezum:

  • Of 103 men, 36 kept taking the drug. Early bleeding was 11.1% in this group and 4.5% in the others, with no statistical difference, and no one had a serious complication. Symptom relief was similar.9
  • Of 80 men, 37 kept taking the drug. Blood in the urine that needed some treatment occurred in 21.6% of this group and 4.7% of the others. All were treated with bladder irrigation through the catheter, for about 1 day, with no transfusion and no repeat surgery.10

The Asian consensus agreed that low-dose aspirin can be continued. For other drugs, it suggested stopping them after discussion with the patient's other doctors, based on very low evidence, and reached no agreement for men who cannot stop.12 Never stop an anticoagulant or antiplatelet drug on your own: the decision is made case by case, together with the doctor who prescribed it.

For men who cannot stop the drug, the European guideline describes laser enucleation as done safely in men on anticoagulants or antiplatelet drugs.1 In my practice, HoLEP is possible even in men who take blood thinners.

How I approach it

I was one of the pioneers of Rezum in Brazil, performing some of the first procedures in the country in July 2023, and I am one of the urologists with the highest number of Rezum procedures in Brazil, with more than 100 cases among my own patients and proctoring. As a proctor, I guide urologists from many parts of São Paulo and Brazil through their first cases.

In my practice, Rezum is done under local anesthesia with sedation, without a hospital stay. In men who depend on a catheter or take blood thinners, I assess the prostate, the bladder, other illnesses and what you want to preserve. I also go over the other techniques, such as HoLEP, and we make the decision together and, when needed, with the doctor who prescribed the medication. The first consultation can be online, in English.

When to see a urologist

  • If you have a catheter because of your prostate and want to know whether it can come out
  • If an attempt to remove the catheter did not work
  • If you take an anticoagulant or antiplatelet drug and need prostate treatment
  • If you were told you cannot have surgery because of other illnesses

Send your case

If you take blood thinners or have a catheter and would like my opinion on your case before a consultation, fill in the form below. Tell me which medications you use and how long you have had the catheter. It goes to my office, and you will get a reply within 24 hours by email or WhatsApp. The form does not replace a consultation: it helps plan the next step.

Frequently asked questions

Can men who depend on a catheter have Rezum?

Yes. In a review of 24 studies of men who depended on a catheter, the catheter was removed in 68% to 100% of cases after Rezum, and the need for retreatment was generally below 15%.2 Most of these studies were not randomized. In practice, each case is assessed at the consultation.

How long after Rezum does the catheter come out in men who already depended on one?

Usually later than in men who did not have a catheter. In a two-center registry, men were catheter-free after about 26 days, as a median.6 In a Canadian study, 49% could not void at the first attempt, at 14 days, and 79% were catheter-free afterward.4 An expert consensus considers it reasonable to try again for up to 3 months.12

Rezum or TURP for men who depend on a catheter?

In a study from Saudi Arabia, 90.2% of men voided without a catheter after Rezum and 92.7% after TURP. The catheter stayed longer after Rezum, and the operation and hospital stay were shorter.7 The full comparison is in Rezum or TURP.

What lowers the chance of success?

In a Canadian study, draining 1 liter or more of urine at the time of retention was the only factor linked to failure.4 In a Swiss series, having a catheter beforehand and having a median lobe raised the risk that the catheter could not be removed.13

Can men on anticoagulants or antiplatelet drugs have Rezum?

Yes, with precautions. In two studies from Japan, men who stayed on these drugs had more blood in the urine, but none needed a transfusion or repeat surgery.9,10 Urological societies have no formal recommendation on managing anticoagulants for Rezum.11 The decision about the medication is made case by case, together with the doctor who prescribed it.

Do I need to stop aspirin before Rezum?

A consensus of urologists from Asia and the Pacific agreed that low-dose aspirin can be continued. For other blood thinners, the consensus suggests stopping them after discussion with the patient's other doctors, based on very low evidence.12 Never stop a medication on your own.

Is there another option for men who cannot stop their anticoagulant?

The European guideline describes laser enucleation, such as HoLEP, as done safely in men on anticoagulants or antiplatelet drugs.1 In my practice, HoLEP is possible even in men who take blood thinners. I go over every technique with the patient.

Who performs Rezum in Brazil for men who depend on a catheter?

I perform Rezum in São Paulo. I am Dr. Petronio Melo, a urologist and robotic surgeon, CRM-SP 157.598 and RQE 70.275. I was one of the pioneers of Rezum in Brazil, performing some of the first procedures in the country in July 2023, and I am one of the urologists with the highest number of Rezum procedures in Brazil, with more than 100 cases among my own patients and proctoring. I also proctor colleagues from São Paulo and other states. My office is in Vila Mariana, and the first consultation can be in person or online, in English.

References

  1. EAU Guidelines on the Management of Non-neurogenic Male LUTS. European Association of Urology; 2026. Treatment chapter. EAU
  2. Scilipoti P, Chicaud M, Abdallah MA, et al. Minimally Invasive Surgical Therapies in Patients with Catheter-Dependent Urinary Retention: A Collaborative Mini-review. Eur Urol Focus. 2026. PubMed
  3. Balsamo R, Tammaro S, Fusco F, et al. Patients with frailty, benign prostatic hyperplasia and indwelling bladder catheter: What are the 1-year outcomes after Rezūm therapy? Curr Urol. 2025;19(6):396-400. PubMed
  4. Ramjiawan R, Chung D, Fidel MG, et al. Efficacy of Rezūm water vapor therapy for the treatment of catheter-dependent urinary retention: a single-center, Canadian experience. Can Urol Assoc J. 2025;19(1):E18-E24. PubMed
  5. Siu BWH, Man JKH, Ho JMH, et al. The double-decker technique for transurethral water vapor therapy (Rezūm) in catheter-dependent patients: A step-by-step guide and results from a prospective registry. Investig Clin Urol. 2026;67(4):375-382. PubMed
  6. McVary KT, Holland B, Beahrs JR. Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 2020;23(2):303-308. PubMed
  7. Tayeb W, Azhar RA, Subahi M, et al. Rezŭm water vaporization therapy versus transurethral resection of the prostate in the management of refractory urine retention: matched pair comparative multicenter experience. World J Urol. 2024;42(1):48. PubMed
  8. Siu BWH, Ho JMH, Yuen SKK, et al. Transurethral water vapor therapy (Rezūm) for acute urinary retention with obstructive uropathy: a prospective cohort study with one-year follow-up. Prostate Int. 2025;13(4):258-263. PubMed
  9. Fujisawa N, Washino S, Yasuda Y, et al. Safety and Efficacy of Rezūm Water Vapor Energy Therapy for Benign Prostatic Hyperplasia With Continued Antithrombotic Therapy: A Comparative Study. Low Urin Tract Symptoms. 2026;18(5):e70094. PubMed
  10. Moriwake T, Tominaga Y, Katayama S, et al. Safety and efficacy of Rezūm water vapour energy therapy in BPH patients receiving antithrombotic therapy: A Japanese single-centre experience. BJUI Compass. 2026;7(2):e70170. PubMed
  11. Coscarella M, Secco S, Elterman DS, et al. Management of NOACs in patients undergoing water vapour thermal therapy (REZUM) for benign prostatic obstruction: a comprehensive review. World J Urol. 2025;44(1):52. PubMed
  12. Siu BWH, Ho JMH, Fam XI, et al. Asia-Pacific collaborative consensus statements on water vapor thermal therapy (Rezūm) incorporating a systematic review, a two-round Delphi survey, and a consensus meeting. Prostate Int. 2026;14(2):173-190. PubMed
  13. Bausch K, Zahiti L, Schrutt M, et al. Water vapor thermal therapy of lower urinary tract symptoms due to benign prostatic obstruction: efficacy and safety analysis of a real-world cohort of 211 patients. World J Urol. 2023;41(6):1605-1612. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation5.0186 Google reviews

Related guides